Abnormal circulating cells and splenic involvement in Hodgkin's disease. 1976

M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013158 Splenic Diseases Diseases involving the SPLEEN. Disease, Splenic,Diseases, Splenic,Splenic Disease

Related Publications

M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
May 1977, Lancet (London, England),
M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
October 1975, British journal of haematology,
M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
July 1984, Canadian Medical Association journal,
M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
November 1984, Archives of internal medicine,
M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
July 1972, British medical journal,
M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
January 1989, Cancer treatment and research,
M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
August 1947, Annals of internal medicine,
M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
January 2004, Journal of pediatric hematology/oncology,
M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
July 1974, Cancer,
M R Halie, and J Hamers, and N Van Larebeke, and W Z Van Hove, and H O Nieweg
May 1973, National Cancer Institute monograph,
Copied contents to your clipboard!